Trial intelligence / Profile preview

Topical lidocaine before Nd:YAG laser treatment for cosmetic periorbital and temporal veins

ACTRN12613000996763Phase 4Completed

Sponsor
University of Toronto
Start
Jul 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of lidocaine in None, sponsored by University of Toronto. Primary endpoint: Pain during laser treatment. Started Jul 2013; status: completed.

02

Drugs

lidocaine

Beyond the preview

Go deeper on ACTRN12613000996763.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12613000996763.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call